Valuation : Clover Corporation Limited

Market Cap 158M 114M 97.86M 92.07M 84.11M 157M 10.74B 1.09B 422M 5.51B 427M 418M 17.75B P/E 2026 *
16.2x
P/E 2027 * 11.8x
Enterprise Value 155M 112M 96.43M 90.73M 82.88M 155M 10.58B 1.07B 416M 5.43B 421M 412M 17.49B EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.3x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day+7.34%
1 week-2.56%
Current month+3.83%
1 month+1.06%
3 months+3.26%
6 months+26.67%
Current year+20.25%
1 week 0.87
Extreme 0.87
0.96
1 month 0.87
Extreme 0.87
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 2014-11-10
Director of Finance/CFO - 2021-05-05
Chief Operating Officer - 2011-02-02
Director TitleAgeSince
Director/Board Member - 2014-11-10
Chairman - 2017-09-20
Director/Board Member - 2017-01-31
Date Insider Type Main position Quantity % Market Cap. Importance
11/18/25 Sell

Chief Executive Officer

255,199 0.1528%
11/18/25 Buy

Chief Executive Officer

529,638 0.3171%
11/6/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+7.34%-2.56%+68.14%-6.86% 106M
+0.52%-1.03%+14.06%+64.58% 12.2B
-0.81%-1.17%-21.04%+278.55% 9.17B
+1.23%+0.30%-17.54%-49.87% 2.43B
+2.90%-1.53%-15.27%-7.48% 1.47B
+0.04%-0.26%+22.78%+75.74% 1.37B
+1.73%-0.40%+22.70%-19.61% 1.28B
-0.10%-2.81%-75.66%-74.90% 1.21B
-1.54%+2.07%-38.34% - 1.16B
-0.35%+4.76%-59.87%-68.35% 1.02B
Average +1.10%-0.02%-10.00%+21.31% 3.14B
Weighted average by Cap. +0.22%-0.31%-6.88%+103.39%

Financials

2026 *2027 *
Net sales 94M 67.76M 58.31M 54.86M 50.11M 93.74M 6.4B 648M 252M 3.28B 254M 249M 10.57B 116M 83.69M 72.01M 67.75M 61.89M 116M 7.9B 801M 311M 4.05B 314M 307M 13.06B
Net income 9.8M 7.06M 6.08M 5.72M 5.22M 9.77M 667M 67.58M 26.22M 342M 26.53M 25.95M 1.1B 13.5M 9.73M 8.37M 7.88M 7.2M 13.46M 919M 93.1M 36.13M 471M 36.54M 35.74M 1.52B
Net Debt -2.3M -1.66M -1.43M -1.34M -1.23M -2.29M -157M -15.86M -6.15M -80.31M -6.23M -6.09M -259M -7.2M -5.19M -4.47M -4.2M -3.84M -7.18M -490M -49.65M -19.27M -251M -19.49M -19.06M -810M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
26-09-04 A$0.9500 +7.34% 117,767
26-09-03 A$0.8850 +1.72% 15,479
26-09-01 A$0.8700 -4.92% 26,873
26-08-31 A$0.9150 -6.15% 11,960
26-08-28 A$0.9750 +7.73% 18,009
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9500AUD
Average target price
1.280AUD
Spread / Average Target
+34.74%

Annual profits - Rate of surprise